OSI Pharmaceuticals
| Use attributes for filter ! | |
| Headquarters | Farmingdale |
|---|---|
| New York | |
| United States | |
| Number of employees | 554 (2007–2002) |
| Parent organizations | Astellas Pharma |
| Founded | 1983 |
| Subsidiaries | Prosidion Limited |
| Oldtech Inc | |
| OSI Pharmaceuticals (UK) Ltd | |
| OSI Eyetech, Inc | |
| Key people | Colin Goddard |
| Michael G. Atieh | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 3110219 |
About OSI Pharmaceuticals
OSI Pharmaceuticals, Inc. was an American pharmaceutical company formerly based on Long Island, New York with facilities in Colorado, New Jersey and the United Kingdom. On Sunday, May 16, 2010 OSI agreed to be acquired by Japan-based, TSE-listed Astellas Pharma for $4. 0 billion. The deal was closed on June 9, 2010.
